Transparency Market Research Reports included a detailed market survey and analysis trends on “D-Dimer Market ”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.D-dimer comprises of two D fragments of the fibrin
protein that get cross-linked after fibrinolysis of a blood clot, which
is found in the human blood samples. The concentration of these D-dimers
present in the patient blood samples help in the diagnosis of
thrombosis. This test becomes very useful for those patients who are
susceptible towards thrombotic disorders like venous thromboembolism. On
the basis of disease diagnoses, the D-dimer market can be classified
into three major segments namely, pulmonary embolism, deep venous
thrombosis and others.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/d-dimer-market.html
Major driving
factors for the growth of this market include, increasing prevalence of
various cardiovascular and pulmonary diseases, rising incidence of heart
strokes, pulmonary embolisms etc. and increasing demand for
technologically advanced coagulation testing methods. Increasing
prevalence of various cardiovascular and pulmonary diseases can cause
life threatening problems, when accompanied by blood clots in the
arterial or pulmonary pathway. Thus, the demand for D-dimer tests will
augment, and hence will contribute towards the growth of the overall
market. Technological advancement in these D-dimer tests will bring more
revenues to this market in the coming future. Specific and more
sensitive markers are now being used to make these tests more accurate
and reliable, which now encompasses automated instrumentation which will
further make these tests more standardized.
Geographically,
North America dominates the D-dimer market followed by Europe. Major
factors responsible for the dominance of these regions in this market
are demand for advanced diagnostics for these life threatening blood
clots inside human organ systems. Asia-Pacific region exhibited the
fastest rate of growth due to increasing prevalence of cardiovascular
diseases in the region combined with increasing affordability and
awareness about these diagnostic tests. Some of the key players
operating in this market are Abbott Laboratories, Inc., Beckman Coulter
Inc.,Bio/Data Corporation,Becton, Dickinson and Company,Corgenix, F.
Hoffmann-La Roche Ltd., NANOGEN, Siemens Healthcare, Thermo Fischer
Scientific, Inc., and Trinity Biotech plc.
This research report analyzes this market depending
on its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include
- North
America
- Asia
Pacific
- Europe
- Rest
of the World
This report provides comprehensive
analysis of
- Market
growth drivers
- Factors
limiting market growth
- Current
market trends
- Market
structure
- Market projections for upcoming years
Transparency
Market Research (TMR) is a market intelligence company providing global
business research reports and consulting services. Our exclusive blend
of quantitative forecasting and trends analysis provides forward-looking
insights for thousands of decision-makers.
No comments:
Post a Comment